Welcome to our dedicated page for Elanco Animal Health news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health stock.
Elanco Animal Health (ELAN) delivers innovative health solutions for pets and livestock worldwide. This dedicated news hub provides investors and industry professionals with essential updates on corporate developments, product innovations, and strategic initiatives shaping the animal health sector.
Access real-time press releases, earnings announcements, and regulatory filings alongside analysis of ELAN's advancements in veterinary pharmaceuticals. Our curated collection simplifies tracking of:
- Quarterly financial results and investor communications
- New product launches and FDA approvals
- Strategic partnerships and R&D milestones
- Industry leadership initiatives and sustainability efforts
Bookmark this page for streamlined access to verified ELAN updates. Combine our news feed with SEC filings and market analysis tools for comprehensive due diligence in the dynamic animal health market.
Elanco Animal Health reported revenue of $1,205 million and net income of $32 million in the first quarter of 2024. Adjusted EBITDA was $294 million, with adjusted EPS of $0.34. The company updated its full-year 2024 financial guidance, expecting revenue of $4,460 to $4,515 million and adjusted EPS of $0.88 to $0.96.
FAQ
What is the current stock price of Elanco Animal Health (ELAN)?
What is the market cap of Elanco Animal Health (ELAN)?
